Glycated albumin and calprotectin levels in gingival crevicular fluid from patients with periodontitis and type 2 diabetes

Journal of Periodontology

Volumn 85, Issue 12, 2014, Pages 1667-1675

  Kajiura, Yukari ^a   Bando, Mika ^a   Inagaki, Yuji ^a   Nagata, Toshihiko ^a   Kido, Jun Ichi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Calprotectin; Diabetes mellitus; Diagnosis; Gingival crevicular fluid; Glycated albumin; Periodontics

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ADULT; AGED; AREA UNDER THE CURVE; BLOOD; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; FORECASTING; GINGIVITIS; GLYCOSYLATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOMARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; FORECASTING; GINGIVAL CREVICULAR FLUID; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; ROC CURVE; SERUM ALBUMIN;

EID: 84914145833     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2014.140241     Document Type: Article

References (56)

1. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999;70: 13-29.
2. Chapple IL, Genco R; Working Group 2 of the Joint EFP/AAP Workshop. Diabetes and periodontal diseases: Consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013; 84(Suppl. 4): S106-S112.
3. Mealey BL, Oates TW; American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77: 1289-1303.
4. Powers AC. Diabetes mellitus. In: Longo DL, Fauci AS, Kasper DL, et al., eds. Hallison's Principles of Internal Medicine, 18th ed. New York: McGraw-Hill; 2011: 2980-2987.
5. Nathan DM. Long-Term complications of diabetes mellitus. N Engl J Med 1993;328: 1676-1685.
6. Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheroscler Rep 2014;16: 419.
7. Furusyo N, Koga T, Ai M, et al. Plasma glycated albumin level and atherosclerosis: Results from the Kyushu and Okinawa Population Study (KOPS). Int J Cardiol 2013;167: 2066-2072.
8. Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13: 836-840.
9. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993;16: 329-334.
10. Khader YS, Dauod AS, El-Qaderi SS, Alkafajei A, Batayha WQ. Periodontal status of diabetics compared with nondiabetics: A meta-Analysis. J Diabetes Complications 2006;20: 59-68.
11. Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: A two-way relationship. Diabetologia 2012; 55: 21-31.
12. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M. Glycemic control and alveolar bone loss progression in type 2 diabetes. Ann Periodontol 1998;3: 30-39.
13. Lalla E, Lamster IB, Drury S, Fu C, Schmidt AM. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: Potential mechanisms underlying diabetic complications, including diabetesassociated periodontitis. Periodontol 2000 2000;23: 50-62.
14. Ryan ME, Carnu O, Kamer A. The influence of diabetes on the periodontal tissues. J AmDent Assoc 2003;134: 34S-40S.
15. Gurav A, Jadhav V. Periodontitis and risk of diabetes mellitus. J Diabetes 2011;3: 21-28.
16. Ritchie CS. Mechanistic links between type 2 diabetes and periodontitis. J Dent 2009;37: S578-S579.
17. Schmidt AM, Weidman E, Lalla E, et al. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: A potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 1996;31: 508-515.
18. Zizzi A, Tirabassi G, Aspriello SD, Piemontese M, Rubini C, Lucarini G. Gingival advanced glycation end-products in diabetes mellitus-Associated chronic periodontitis: An immunohistochemical study. J PeriodontalRes 2013;48: 293-301.
19. Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: A systematic review and meta-Analysis. Diabetes Care 2010;33: 421-427.
20. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979;76: 4258-4261.
21. Anguizola J, Matsuda R, Barnaby OS, et al. Review: Glycation of human serum albumin. Clin Chim Acta 2013;425: 64-76.
22. Furusyo N, Koga T, Ai M, et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: Results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 2011;54: 3028-3036.
23. Yang C, Li H, Wang Z, et al. Glycated albumin is a potential diagnostic tool for diabetes mellitus. Clin Med 2012;12: 568-571.
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37 (Suppl. 1): S81-S90.
25. Suzuki S, Koga M, Amamiya S, et al. Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus. Diabetologia 2011;54: 2247-2253.
26. Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010;57: 751-762.
27. Furusyo N, Hayashi J. Glycated albumin and diabetes mellitus. Biochim Biophys Acta 2013;1830: 5509-5514.
28. Fagerhol MK, Andersson KB, Naess-Andersen CF, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith UL, Dedman JR, eds. Stimulus Response Coupling: The Role of Intracellular Calcium-Binding Proteins. Boca Raton, FL: CRC Press; 1990: 187-210.
29. Berntzen HB, Munthe E, Fagerhol MK. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989;16: 1416-1420.
30. Fagerhol MK. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet 2000;356: 1783-1784.
31. Golden BE, Clohessy PA, Russell G, Fagerhol MK. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child 1996;74: 136-139.
32. Kido J, Nakamura T, Kido R, et al. Calprotectin, a leukocyte protein related to inflammation, in gingival crevicular fluid. J Periodontal Res 1998;33: 434-437.
33. Kido J, Nakamura T, Kido R, et al. Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. J Clin Periodontol 1999;26: 653-657.
34. Nakamura T, Kido J, Kido R, et al. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. J Periodontol 2000;71: 361-367.
35. Becerik S, Afacan B, Oztürk VÖ , Atmaca H, Emingil G. Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-Terminal telopeptid levels in health and different periodontal diseases. Dis Markers 2011;31: 343-352.
36. Andersen E, Dessaix IM, Perneger T, Mombelli A. Myeloid-related protein (MRP8/14) expression in gingival crevice fluid in periodontal health and disease and after treatment. J Periodontal Res 2010;45: 458-463.
37. Kaner D, Bernimoulin JP, Dietrich T, Kleber BM, Friedmann A. Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis. J Periodontal Res 2011;46: 417-426.
38. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
39. Hiroshima Y, Bando M, Inagaki Y, et al. Resistin in gingival crevicular fluid and induction of resistin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. J Periodontal Res 2012;47: 554-562.
40. Bulkacz J, Carranza FA. Defense mechanisms of the gingiva. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA, eds. Carranza's Clinical Periodontology, 11th ed. Philadelphia: W.B. Saunders; 2012: 66-68.
41. Ngo LH, Veith PD, Chen YY, Chen D, Darby IB, Reynolds EC. Mass spectrometric analyses of peptides and proteins in human gingival crevicular fluid. J Proteome Res 2010;9: 1683-1693.
42. Kido J, Bando M, Hiroshima Y, et al. Analysis of proteins in human gingival crevicular fluid by mass spectrometry. J Periodontal Res 2012;47: 488-499.
43. Kumeda Y, Inaba M, Shoji S, et al. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clin Endocrinol (Oxf) 2008;69: 556-561.
44. Takahashi S, Uchino H, Shimizu T, et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: Usefulness of GA for evaluation of short-Term changes in glycemic control. Endocr J 2007;54: 139-144.
45. Kalra N, Pradeep AR, Priyanka N, Kumari M. Association of stem cell factor and high-sensitivity C reactive protein concentrations in crevicular fluid and serum in patients with chronic periodontitis with and without type 2 diabetes. J Oral Sci 2013;55: 57-62.
46. Kardesxler L, Buduneli N, Biyikoʇlu B, Cxetinkalp S, Kütükcxüler N. Gingival crevicular fluid PGE2, IL-1beta, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. Clin Biochem 2008; 41: 863-868.
47. Bulut U, Develioglu H, Taner IL, Berker E. Interleukin-1 beta levels in gingival crevicular fluid in type 2 diabetes mellitus and adult periodontitis. J Oral Sci 2001;43: 171-177.
48. Noguchi E, Kato R, Ohno K, et al. The apolipoprotein B concentration in gingival crevicular fluid increases in patients with diabetes mellitus. Clin Biochem 2014;47: 67-71.
49. Wang F, Ma X, Hao Y, et al. Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance. PLoS One 2012;7: e51098.
50. Kido J, Hayashi N, Kataoka M, Nagata T. Calprotectin expression in human monocytes: Induction by Porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-Alpha, and interleukin-1beta. J Periodontol 2005; 76: 437-442.
51. Lee MJ, Lee JK, Choi JW, et al. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One 2012;7: e38801.
52. Bando M, Zou X, Hiroshima Y, et al. Mechanism of interleukin-1a transcriptional regulation of S100A9 in a human epidermal keratinocyte cell line. Biochim Biophys Acta 2013;1829: 954-962.
53. Kaner D, Bernimoulin JP, Kleber BM, Heizmann WR, Friedmann A. Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis. J Periodontal Res 2006;41: 132-139.
54. Becerik S, Gürkan A, Afacan B, et al. Gingival crevicular fluid osteocalcin, N-Terminal telopeptides, and calprotectin levels in cyclosporin A-induced gingival overgrowth. J Periodontol 2011;82: 1490-1497.
55. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004;343: 1-16.
56. Kido J, Abe K, Yatsushiro S, et al. Determination of calprotectin in gingival crevicular fluid by immunoassay on a microchip. Clin Biochem 2012;45: 1239-1244.